Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
ACADIA Pharmaceuticals Inc
SWB:DR6
ACADIA Pharmaceuticals Inc
SWB:DR6
Price:
18.905
EUR
-0.66%
Market Closed
Market Cap:
€3.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
DR6 Price Forecast
Based on 21 analysts
Based on 21 analysts
+54% Upside
from
€18.905
today
ACADIA Pharmaceuticals Inc (DR6)’s 12-month stock price forecast through November 2027 has a consensus target of €29.115, implying 54% upside. The forecast is based on price targets from 21 Wall Street analysts.
DR6 Analyst Rating
No ratings yet
No ratings yet
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DR6's stock price target?
Price Target
29.115
EUR
29.115
EUR
According to Wall Street analysts, the average 1-year price target for DR6 is 29.115 EUR with a low forecast of 14.451 EUR and a high forecast of 35.681 EUR.
What is the Revenue forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Gross Profit over the next 8 years is 9%.
What is the Operating Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
27%
27%
The compound annual growth rate for Operating Income over the next 8 years is 27%.
What is the Pre-Tax Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
33%
33%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 33%.
What is the Net Income forecast for ACADIA Pharmaceuticals Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Net Income over the next 8 years is 9%.
